Development Level

Tbio 4 | 10,625
Tchem 1 | 1,890

IMPC Term

increased leukocyte cell numbe... 2 | 37
abnormal heart morphology 1 | 51
decreased T cell number 1 | 31
decreased monocyte cell number 1 | 28
embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
enlarged heart 1 | 111
increased CD4-positive, alpha ... 1 | 15
increased circulating alkaline... 1 | 119
increased eosinophil cell numb... 1 | 9
increased grip strength 1 | 83
increased lymphocyte cell numb... 1 | 9
increased neutrophil cell numb... 1 | 15
preweaning lethality, complete... 1 | 633

Disease

Cancer 3 | 2,346
Rheumatoid Arthritis 3 | 1,160
ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
Asthma 2 | 349
Hypersensitivity reaction type II disease 2 | 235
Malaria 2 | 140
Multiple Sclerosis 2 | 498
lung cancer 2 | 4,466
osteosarcoma 2 | 7,933
Adult T-Cell Lymphoma/Leukemia 1 | 30
Allergic conjunctivitis 1 | 25
Allergic hypersensitivity disease 1 | 123
Anemia 1 | 252
Ankylosing spondylitis 1 | 138
Arthritis 1 | 248
Arthritis, Psoriatic 1 | 15
Autoimmune Diseases 1 | 33
Berylliosis 1 | 16
Celiac disease 1 | 112
Cervical dystonia 1 | 9
Chloracne 1 | 32
Collagen disease 1 | 25
Coronary artery disease 1 | 240
Crohn Disease 1 | 97
Crohn's disease 1 | 304
DOID:3394 1 | 1
Dengue disease 1 | 19
Encephalitis 1 | 54
Gastrointestinal system disease 1 | 50
HIV Infections 1 | 100
Hepatic encephalopathy 1 | 25
Hepatitis B 1 | 103
Herpes simplex 1 | 19
Human immunodeficiency virus infectious disease 1 | 92
Hyperthyroidism 1 | 50
Hypothyroidism 1 | 89
Inflammatory bowel disease 1 | 142
Influenza 1 | 142
Kidney disease 1 | 396
LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO 1 | 1
Leprosy 1 | 77
Leukemia, Myelocytic, Acute 1 | 113
Lung disease 1 | 132
Lyme disease 1 | 23
Lymphoma, T-Cell, Cutaneous 1 | 21
Multiple myeloma 1 | 1,327
Myocardial Infarction 1 | 126
Neuromyelitis optica 1 | 20
Neuropathy 1 | 210
PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO (finding) 1 | 2
Peripheral Neuropathy 1 | 303
Peripheral T-cell lymphoma 1 | 24
Sepsis 1 | 21
Syphilis 1 | 18
Tetanus 1 | 66
Thrombocytopenia 1 | 105
Thyroiditis 1 | 25
Toxic shock syndrome 1 | 28
Type 1 diabetes mellitus 1 | 101
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 765
cutaneous lupus erythematosus 1 | 1,056
diabetes mellitus 1 | 1,663
interstitial cystitis 1 | 2,299
medulloblastoma, large-cell 1 | 6,234
non primary Sjogren syndrome sicca 1 | 840
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
primary Sjogren syndrome 1 | 789
sarcoidosis 1 | 358
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

2R37AI033068-11 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Lymphotoxin-alpha LTA Tbio Non-IDG -2.84770 612.8 461
Probable ATP-dependent RNA helicase DDX41 DDX41 Tbio Enzyme -3.57193 3737.6 208
Tumor necrosis factor receptor superfamily member 14 TNFRSF14 Tbio Non-IDG -2.33206 264.6 453
T-cell-specific surface glycoprotein CD28 CD28 Tchem Non-IDG -1.85970 107.1 1174
Tumor necrosis factor receptor superfamily member 3 LTBR Tbio Non-IDG -2.29013 239.4 524